We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+7.8%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$484B
AUM Growth
+$29.1B
Cap. Flow
-$16.6B
Cap. Flow %
-3.43%
Top 10 Hldgs %
36.47%
Holding
15,826
New
1,205
Increased
5,575
Reduced
7,223
Closed
1,563

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$545M
2
DXCM icon
DexCom
DXCM
+$457M
3
T icon
AT&T
T
+$431M
4
PANW icon
Palo Alto Networks
PANW
+$416M
5
HUM icon
Humana
HUM
+$394M

Sector Composition

Rank Sector Weight
1 Technology 3.03%
2 Healthcare 2.92%
3 Consumer Discretionary 1.99%
4 Financials 1.93%
5 Industrials 1.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WLDN icon
13576
PUT
Willdan Group
WLDN
$1.32B
$3.83K ﹤0.01%
+200
New +$3.36K
UXIN
13577
CALL
Uxin Ltd
UXIN
$262M
$3.79K ﹤0.01%
231
+80
+53% +$1.17K
BNIXR
13578
DELISTED
Bannix Acquisition Corp. Right
BNIXR
$3.77K ﹤0.01%
26,727
+9,806
+58% +$1.41K
PSNL icon
13579
CALL
Personalis
PSNL
$1.52B
$3.76K ﹤0.01%
2,000
-58,700
-97% -$133K
MNTS icon
13580
PUT
Momentus
MNTS
$92.7M
$3.75K ﹤0.01%
1
HGEN
13581
DELISTED
HUMANIGEN, INC.
HGEN
$3.75K ﹤0.01%
24,586
+24,410
+13,869% +$3.8K
ACTG icon
13582
PUT
Acacia Research
ACTG
$448M
$3.74K ﹤0.01%
900
+800
+800% +$3.23K
EIG icon
13583
PUT
Employers Holdings
EIG
$874M
$3.74K ﹤0.01%
100
-500
-83% -$19.6K
SIEB icon
13584
PUT
Siebert Financial
SIEB
$79.7M
$3.72K ﹤0.01%
+1,500
New +$3.4K
EWS icon
13585
PUT
iShares MSCI Singapore ETF
EWS
$1.16B
$3.7K ﹤0.01%
200
-300
-60% -$5.82K
CXDO icon
13586
PUT
Crexendo
CXDO
$221M
$3.7K ﹤0.01%
+2,100
New +$3.37K
SKGRW
13587
DELISTED
SK Growth Opportunities Corporation Warrant
SKGRW
$3.7K ﹤0.01%
26,381
+10,263
+64% +$1.66K
ONCT
13588
CALL
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$3.69K ﹤0.01%
535
+80
+18% +$528
BDRY icon
13589
Breakwave Dry Bulk Shipping ETF
BDRY
$31.4M
$3.69K ﹤0.01%
665
-11,031
-94% -$83.7K
SGOL icon
13590
PUT
abrdn Physical Gold Shares ETF
SGOL
$7.47B
$3.67K ﹤0.01%
200
-1,200
-86% -$22.7K
GCMGW
13591
DELISTED
GCM Grosvenor Inc Warrant
GCMGW
$3.66K ﹤0.01%
+12,502
New +$5.24K
IVDAW icon
13592
Iveda Solutions Warrant
IVDAW
$77.7K
$3.65K ﹤0.01%
15,219
-5,819
-28% -$1.49K
CNDA.WS
13593
DELISTED
Concord Acquisition Corp II Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
CNDA.WS
$3.63K ﹤0.01%
90,741
+75,979
+515% +$4.34K
ATXS
13594
DELISTED
Astria Therapeutics
ATXS
$3.62K ﹤0.01%
435
-18,349
-98% -$212K
PNT
13595
PUT
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$3.62K ﹤0.01%
400
+300
+300% +$2.65K
ATLO icon
13596
PUT
AMES National
ATLO
$280M
$3.61K ﹤0.01%
+200
New +$3.76K
GDNRW
13597
DELISTED
Gardiner Healthcare Acquisitions Corp. Warrant
GDNRW
$3.6K ﹤0.01%
51,506
+6,890
+15% +$605
TNON icon
13598
Tenon Medical
TNON
$2.67M
$3.6K ﹤0.01%
+5
New +$18.4K
KRRO icon
13599
CALL
Korro Bio
KRRO
$194M
$3.6K ﹤0.01%
208
-434
-68% -$8.42K
CBIO
13600
Crescent Biopharma
CBIO
$635M
$3.59K ﹤0.01%
+21
New +$3.52K

Similar funds

Citadel Advisors's Q2 2023 Portfolio in Review

As of Q2 2023, Citadel Advisors held 15,826 positions worth $484B, up 6.4% from $455B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Citadel Advisors withdrew a net $16.6B in Q2 2023, closing 1,563 positions and reducing 7,223 holdings. Its most notable exit was State Street Industrial Select Sector SPDR ETF, an estimated $192M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3.2% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Citadel Advisors opened a new position in BILL Holdings worth $222M.

  • Citadel Advisors's largest Q2 2023 buy was BILL Holdings: 1,901,064 shares worth $222M.
  • Citadel Advisors added most to Microsoft in Q2 2023, an estimated $640M increase.
  • Citadel Advisors's biggest Q2 2023 reduction was NVIDIA, cutting an estimated $545M.
  • Citadel Advisors fully exited State Street Industrial Select Sector SPDR ETF in Q2 2023, selling an estimated $192M.
  • Citadel Advisors's ten largest holdings make up 36% of its $484B portfolio in Q2 2023.
  • Citadel Advisors opened 1,205 new positions and closed 1,563 in Q2 2023.
  • Citadel Advisors's portfolio value rose 6.4% quarter-over-quarter to $484B.

Based on Citadel Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.